Identification and pathogenicity analysis of a novel non-tuberculous mycobacterium clinical isolate with nine-antibiotic resistance  Z.-Y. Zhang, Z.-Q. Sun, Z.-L. Wang, H.-R. Hu, Z.-L. Wen, Y.-Z. Song, J.-W. Zhao, H.-H. Wang, X.-K. Guo, S.-L. Zhang  Clinical Microbiology and Infection  Volume 19, Issue 1, Pages 91-96 (January 2013) DOI: 10.1111/j.1469-0691.2012.03818.x Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Phylogenetic relationships of JDM601 to other Mycobacterium species. Two trees were constructed using the neighbour-joining method based on 16S rRNA (a) and hsp65 (b) gene sequences. Percentages indicated at the nodes represent bootstrap levels supported by 1000 resampled datasets. Rhodococcus equi was used as an outgroup for both trees. Bar, 1% (a) and 0.5% (b) sequence difference. Clinical Microbiology and Infection 2013 19, 91-96DOI: (10.1111/j.1469-0691.2012.03818.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Comparison chart of JDM601 with Mycobacterium nonchromogenicum. All fatty acids found in sample and library entries were vertically listed in elution order on the left side of the chart. A scale of percentages was printed across the bottom of the chart. For each acid, the bar represented a ± 2 standard deviation window around the entry mean, which is identified by a bold vertical line. The oval on the bar indicates the amount of that acid in JDM601. SF, Summed Feature. Clinical Microbiology and Infection 2013 19, 91-96DOI: (10.1111/j.1469-0691.2012.03818.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions